Navigation Links
Nutrastar International Inc. Announces That Acclaimed Value Investor, Accretive Capital Partners, Significantly Increased Its Ownership of the Company through Private Transactions
Date:12/26/2013

HARBIN, China, Dec. 26, 2013 /PRNewswire-FirstCall/ -- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products made from commercially cultivated cordyceps militaris, including medicinal products, functional health beverages, and organic and specialty foods, today announced that its long-term shareholder and value-added investor, Accretive Capital Partners ("Accretive Capital"), has increased its ownership stake by approximately 96% through several private transactions with management and a third party shareholder.

Established in 2000, Accretive Capital Partners is a private investment fund founded and operated by Richard Fearon, an active member of the Board of Directors of Nutrastar.  Accretive Capital seeks to partner with exceptional managers of undervalued small and micro-cap public companies which represent attractive take-private candidates.  A renowned value investor, Accretive Capital has received top fund rankings by Morningstar, Barron's Magazine, Bloomberg, Lipper, Barclay Managed Funds, and Infovest21, among others, and was recipient of HFM Week magazine's prestigious Best Single Manager Long-Term Performance Award in 2011 among all United States hedge funds under $250 million. 

On December 23, 2013, Accretive Capital purchased 800,000 common shares and 2,750 preferred shares (convertible into common stock at the ratio of 1:10) of the Company for a total of 827,500 common share equivalents in private transactions.  Post transaction, Accretive Capital increased its ownership from 5.3% to approximately 10.4% and has been building its position in Nutrastar since it first invested in January 2011.

The transactions included the acquisition of 700,000 common shares from Nutrastar's Chief Executive Officer and Founder, Ms. Lianyun Han, thus decreasing her voting power from approximately 52.7% to 47.2%, on a fully diluted basis.  Ms. Han commented, "In response to market perceptions about public companies controlled by one individual, I agreed to reduce my stake by providing Accretive the additional ownership it was seeking.  It was my pleasure to offer this sale to Accretive, as they are loyal, value-added, and long-term partners who share our values of being honest custodians of investor capital and our vision of benefitting society broadly."

She continued, "With these transactions, Nutrastar is no longer controlled by one individual, which we hope will give shareholders comfort and peace of mind that the Company is taking appropriate measures with well-suited and highly-regarded partners in the United States to ensure its growth and continued success both in China and abroad."

Richard Fearon, Founder and Managing Partner of Accretive Capital Partners and member of Nutrastar's Board of Directors, commented, "We are thrilled to solidify our strong partnership with Ms. Han and the Nutrastar team and we look forward to offering strategic guidance as Nutrastar takes steps to expand internationally."

For more information on this announcement, please refer to the Schedule 13D and Form 4 to be filed with the Securities and Exchange Commission.

About Nutrastar International Inc.

Nutrastar is a China based leading producer and supplier of premium branded consumer products including commercially cultivated Cordyceps Militaris, functional health beverages as well as specialty and organic foods. Cordyceps Militaris is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine. The Company is headquartered in Harbin, capital of Heilongjiang Province, with 330 employees, including 21 in R&D, and 149 in sales and marketing. The products of Nutrastar are sold throughout China via a sales and distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com/ or e-mail: ir@nutrastarintl.com

Make sure you are first to receive timely up-to-date information on Nutrastar. Sign up for Nutrastar's email news alert system today at: http://www.nutrastarintl.com/alerts

 Safe Harbor Statement

This news release contains "forward-looking statements" relating to the business of Nutrastar International Inc., its subsidiaries and other affiliate companies.  All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts.  These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions.  These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors.  You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact: 

Howard Gostfrand
American Capital Ventures
Tel:  +1-305-918-7000
Email: info@amcapventures.com


'/>"/>
SOURCE Nutrastar International Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nutrastar Releases Record Third Quarter 2013 Results
2. Nutrastar Releases Second Quarter 2013 Results
3. Nutrastar Announces First Quarter 2013 Results, Maintains Full Year Revenue Guidance Range of $44 million to $46 Million
4. Nutrastar Announces Full Year 2012 Results, Issues 2013 Revenue Guidance
5. Nutrastar International Completes Multi-Year Production Expansion Project Bringing Cordyceps Capacity to 100 Tons
6. International Animal/Veterinary Vaccines Market 2013-2018
7. 2013 Report on the International Digital X-Ray Market - Includes Forecast to 2018
8. 2013 Report on the International Cardiac Monitoring & Cardiac Rhythm Management (CRM) Market - Includes Forecasts to 2017
9. 2013 Report on the International Anesthesia And Respiratory Devices Market - Includes Forecastto 2019
10. 2013 Report on the International Pain Management Therapeutics Market - Includes Forecast to 2018
11. ULURU Inc. Announces the Expansion of the International Marketing Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017  NDS received FDA 510(k) ... — a medical-grade battery-powered display stand specifically designed for endoscopy environments. ... transform technology into a clinical solution to support the improvement of ... Innovative Design ... Mobile Wireless Solution ...
(Date:10/7/2017)... Oct. 6, 2017   Provista, a proven ... $100 billion in purchasing power, today announced a new ... The Newsroom is the online home for ... infographics, expert bios, news releases, slideshows and events. ... a wealth of resources at their fingertips, viewers can ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
(Date:10/12/2017)... ... 12, 2017 , ... Farm Forward joins Bon ... leading institutions in announcing the launch of the Leadership Circle , a ... are raised for food. , Founding members of the Leadership Circle also include ...
Breaking Medicine News(10 mins):